BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29063338)

  • 1. Effect of Lipid Surface Composition on the Formation and Structure of Fibrin Clots.
    Bakirova DR; Faizullin DA; Valiullina YA; Salnikov VV; Zuev YF
    Bull Exp Biol Med; 2017 Oct; 163(6):722-725. PubMed ID: 29063338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coarse-grained molecular dynamics simulations of fibrin polymerization: effects of thrombin concentration on fibrin clot structure.
    Yesudasan S; Wang X; Averett RD
    J Mol Model; 2018 Apr; 24(5):109. PubMed ID: 29623504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct interaction of fibrinogen with lipid microparticles modulates clotting kinetics and clot structure.
    Faizullin D; Valiullina Y; Salnikov V; Zuev Y
    Nanomedicine; 2020 Jan; 23():102098. PubMed ID: 31655206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin clot formation under diverse clotting conditions: Comparing turbidimetry and thromboelastography.
    Zeng Z; Fagnon M; Nallan Chakravarthula T; Alves NJ
    Thromb Res; 2020 Mar; 187():48-55. PubMed ID: 31954276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ioxaglate--an ionic low osmolar contrast medium--on fibrin polymerization in vitro.
    Brass O; Belleville J; Sabattier V; Corot C
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):689-97. PubMed ID: 8292718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative modification of fibrinogen inhibits its transformation into fibrin under the effect of thrombin.
    Azizova OA; Piryazev AP; Aseychev AV; Shvachko AG
    Bull Exp Biol Med; 2009 Feb; 147(2):201-3. PubMed ID: 19513421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the alpha C domains of fibrin in clot formation.
    Gorkun OV; Veklich YI; Medved LV; Henschen AH; Weisel JW
    Biochemistry; 1994 Jun; 33(22):6986-97. PubMed ID: 8204632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigations of fibrin clots formation under the effect of thrombin and ancystron].
    Savchuk OM; Chernyshov VI; Volkov HL
    Ukr Biokhim Zh (1999); 2004; 76(3):122-5. PubMed ID: 19621750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of fibrinogen carbamylation on fibrin clot formation and stability.
    Binder V; Bergum B; Jaisson S; Gillery P; Scavenius C; Spriet E; Nyhaug AK; Roberts HM; Chapple ILC; Hellvard A; Delaleu N; Mydel P
    Thromb Haemost; 2017 May; 117(5):899-910. PubMed ID: 28382370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in adsorbed fibrinogen upon conversion to fibrin.
    Evans-Nguyen KM; Fuierer RR; Fitchett BD; Tolles LR; Conboy JC; Schoenfisch MH
    Langmuir; 2006 May; 22(11):5115-21. PubMed ID: 16700602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma.
    Price ME; Cornelius RM; Brash JL
    Biochim Biophys Acta; 2001 Jun; 1512(2):191-205. PubMed ID: 11406096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure.
    Henderson SJ; Xia J; Wu H; Stafford AR; Leslie BA; Fredenburgh JC; Weitz DA; Weitz JI
    Thromb Haemost; 2016 Mar; 115(3):533-42. PubMed ID: 26489782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oxidation-modified fibrinogen on the formation and lysis of fibrin clot in the plasma.
    Piryazev AP; Aseichev AV; Azizova OA
    Bull Exp Biol Med; 2009 Dec; 148(6):881-5. PubMed ID: 21116496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ultrastructure of fibrinogen-420 and the fibrin-420 clot.
    Mosesson MW; DiOrio JP; Hernandez I; Hainfeld JF; Wall JS; Grieninger G
    Biophys Chem; 2004 Dec; 112(2-3):209-14. PubMed ID: 15572250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization.
    Mosesson MW; Hernandez I; Siebenlist KR
    Biophys Chem; 2004 Jul; 110(1-2):93-100. PubMed ID: 15223147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic and mechanical parameters of pure and cryoprecipitate fibrin.
    Marx G; Blankenfeld A
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):73-8. PubMed ID: 8457656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Features of the structure of fibrin clots, connected with conditions of gel formation].
    Savchuk AN; Makogonenko EM
    Ukr Biokhim Zh (1999); 2001; 73(4):123-7. PubMed ID: 12035519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does topology drive fiber polymerization?
    Huang L; Hsiao JP; Powierza C; Taylor RM; Lord ST
    Biochemistry; 2014 Dec; 53(49):7824-34. PubMed ID: 25419972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.